GeneDx Holdings Corp. Annual Deferred Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
GeneDx Holdings Corp. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • GeneDx Holdings Corp. Deferred Income Tax Expense (Benefit) for the quarter ending June 30, 2022 was -$48.6M.
  • GeneDx Holdings Corp. annual Deferred Income Tax Expense (Benefit) for 2023 was -$1.09M, a 97.8% increase from 2022.
  • GeneDx Holdings Corp. annual Deferred Income Tax Expense (Benefit) for 2022 was -$49.1M.
  • GeneDx Holdings Corp. annual Deferred Income Tax Expense (Benefit) for 2021 was $0.000.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.09M +$48M +97.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 -$49.1M -$49.1M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.